• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.子宫颈鳞状细胞癌患者血清中的预处理肿瘤抗原Ta-4
Br J Cancer. 1987 Aug;56(2):157-8. doi: 10.1038/bjc.1987.176.
2
Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.鳞状细胞癌抗原在人宫颈癌中的临床意义。与癌胚抗原和糖类抗原125的比较。
Gynecol Obstet Invest. 1991;32(1):55-8. doi: 10.1159/000292993.
3
Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.治疗前鳞状细胞癌抗原和癌胚抗原在子宫颈鳞状细胞癌中的预后意义。
Gynecol Oncol. 1997 Mar;64(3):418-24. doi: 10.1006/gyno.1996.4589.
4
Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
Cancer. 1984 Oct 15;54(8):1544-6. doi: 10.1002/1097-0142(19841015)54:8<1544::aid-cncr2820540813>3.0.co;2-b.
5
[Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer].[血清肿瘤标志物鳞状细胞癌抗原（SCC）、组织多肽抗原（TATI）和组织多肽特异性抗原（TPS）：在宫颈癌女性患者随访中的价值]
Gynakol Geburtshilfliche Rundsch. 1992;32 Suppl 1:115. doi: 10.1159/000271964.
6
[SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].[鳞状细胞癌抗原作为宫颈癌的肿瘤标志物]
Geburtshilfe Frauenheilkd. 1989 Mar;49(3):266-71. doi: 10.1055/s-2008-1035752.
7
[Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].[血清鳞状细胞癌抗原变化在宫颈复发鳞状细胞癌诊断中的意义及启示]
Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):131-6.
8
[Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].[血清鳞状细胞癌抗原与子宫颈鳞状细胞癌临床病理特征及预后的相关性]
Zhonghua Fu Chan Ke Za Zhi. 2007 Jan;42(1):29-33.
9
Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.鳞状细胞癌抗原、癌胚抗原和糖类抗原19-9联合检测可预测早期子宫颈鳞状细胞癌患者盆腔淋巴结转移及宫旁组织受累情况。
J Obstet Gynaecol Res. 2012 Oct;38(10):1260-5. doi: 10.1111/j.1447-0756.2012.01862.x. Epub 2012 May 8.
10
Squamous cell carcinoma antigen in oral squamous cell carcinomas.口腔鳞状细胞癌中的鳞状细胞癌抗原
Bull Tokyo Med Dent Univ. 1990 Jun;37(1-2):27-34.

引用本文的文献

1
Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma.
Int J Colorectal Dis. 1993 Jul;8(2):98-102. doi: 10.1007/BF00299336.

本文引用的文献

1
Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.鳞状细胞癌肿瘤抗原（TA-4）在预测宫颈癌范围中的价值。
Cancer. 1982 Oct 1;50(7):1294-6. doi: 10.1002/1097-0142(19821001)50:7<1294::aid-cncr2820500712>3.0.co;2-k.
2
The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stages IB and IIA.宫颈癌IB期和IIA期宫旁组织及/或盆腔淋巴结微小浸润的意义。
Gynecol Oncol. 1983 Aug;16(1):56-62. doi: 10.1016/0090-8258(83)90009-4.
3
Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
Am J Obstet Gynecol. 1983 Feb 1;145(3):350-4. doi: 10.1016/0002-9378(83)90723-8.
4
Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
Cancer. 1984 Oct 15;54(8):1544-6. doi: 10.1002/1097-0142(19841015)54:8<1544::aid-cncr2820540813>3.0.co;2-b.
5
Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
Int J Gynecol Pathol. 1984;3(3):291-8. doi: 10.1097/00004347-198403000-00005.
6
The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findinges.宫颈癌的分期：临床分期与病理结果之间不可避免的差异。
Am J Obstet Gynecol. 1971 Aug 1;110(7):973-8. doi: 10.1016/0002-9378(71)90551-5.
7
Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimens.宫颈细胞学标本中肿瘤抗原TA-4的流式细胞术分析。
Cancer. 1986 Apr 1;57(7):1380-4. doi: 10.1002/1097-0142(19860401)57:7<1380::aid-cncr2820570723>3.0.co;2-c.
8
Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
Cancer. 1985 Jul 15;56(2):302-8. doi: 10.1002/1097-0142(19850715)56:2<302::aid-cncr2820560217>3.0.co;2-t.
9
Diagnosis and treatment of microinvasive carcinoma of the cervix uteri.子宫颈微浸润癌的诊断与治疗
Obstet Gynecol. 1977 Jun;49(6):641-53.
10
Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma.
Cancer. 1977 Oct;40(4):1621-8. doi: 10.1002/1097-0142(197710)40:4<1621::aid-cncr2820400435>3.0.co;2-i.

Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.

作者信息

Kenter G, Bonfrer J M, Heintz A P

机构信息

Division of Gynaecology, Netherlands Cancer Institute, Amsterdam.

出版信息

Br J Cancer. 1987 Aug;56(2):157-8. doi: 10.1038/bjc.1987.176.

DOI:10.1038/bjc.1987.176
PMID:3663467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2002153/
Abstract
摘要